O. C. Eren Et Al. , "ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.," Annals of surgical oncology , vol.31, no.10, pp.7068-7069, 2024
Eren, O. C. Et Al. 2024. ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.. Annals of surgical oncology , vol.31, no.10 , 7068-7069.
Eren, O. C., Bagci, P., Balci, S., Ohike, N., Saka, B., Sokmensuer, C., ... Leblebici, C. B.(2024). ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.. Annals of surgical oncology , vol.31, no.10, 7068-7069.
Eren, Ozgur Et Al. "ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.," Annals of surgical oncology , vol.31, no.10, 7068-7069, 2024
Eren, Ozgur C. Et Al. "ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.." Annals of surgical oncology , vol.31, no.10, pp.7068-7069, 2024
Eren, O. C. Et Al. (2024) . "ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.." Annals of surgical oncology , vol.31, no.10, pp.7068-7069.
@article{article, author={Ozgur Can Eren Et Al. }, title={ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.}, journal={Annals of surgical oncology}, year=2024, pages={7068-7069} }